Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
European Journal of Nuclear Medicine|October 1, 1994
Platelet labelling with indium-hydroxypyridinone and indium-hydroxypyranone complexesR D Abeysinghe, B L Ellis, J B PorterEuropean Journal of Nuclear Medicine|November 7, 1999
6-Alkoxymethyl-3-hydroxy-4H-pyranones: potential ligands for cell-labelling with indiumB L Ellis, C B Sampson, R D Abeysinghe, et al.Physics in Medicine and Biology|June 8, 2000
The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overloadM J Farquharson, A P Bagshaw, J B Porter, et al.Blood|July 15, 1996
Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapyJ B Porter, R D Abeysinghe, L Marshall, et al.Experimental Hematology|January 1, 1993
In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesisK P Hoyes, H M Jones, R D Abeysinghe, et al.British Journal of Haematology|January 1, 1990
Secretion of neutrophil secondary granules occurs during granulocyte-macrophage colony stimulating factor induced marginationS Devereux, J B Porter, K P Hoyes, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patientsP Lee, N Mohammed, L Marshall, et al.Blood|November 15, 1991
Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded miceJ B Porter, K P Hoyes, R D Abeysinghe, et al.The Journal of Biological Chemistry|April 5, 1996
The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelatorsR D Abeysinghe, P J Roberts, C E Cooper, et al.British Journal of Haematology|September 1, 1993
Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating siteJ B Porter, R D Abeysinghe, K P Hoyes, et al.Pageof 9